 |
 | Vissza |
Ivić Vedrana; Zjalić Milorad; Blažetić Senka; Fenrich Matija; Labak Irena; Scitovski Rudolf; Szűcs Kálmán Ferenc; Ducza Eszter; Tábi Tamás; Bagaméry Fruzsina; Szökő Éva; Vukovic Rosemary; Roncevic Alen; Mandic Dario; Debeljak Zeljko; Berecki Monika; Balog Marta; Seres-Bokor Adrienn; Sztojkov-Ivanov Anita; Hajagos-Tóth Judit; Gáspár Róbert; et al.:
Elderly rats fed with a high-fat high-sucrose diet developed sex-dependent metabolic syndrome regardless of long-term metformin and liraglutide treatment.
FRONTIERS IN ENDOCRINOLOGY, 14.
ISSN 1664-2392
(2023)
Gáspár Róbert; Hajagos-Tóth Judit; Schaffer Annamária; Kothencz Anna; Siska-Szabó Lilla; Ducza Eszter; Csányi Adrienn; Tábi Tamás; Bagaméry Fruzsina; Szökő Éva; Kovács Orsolya; Barna Tamara; Samavati Reza; Mirdamadi Seyedmohsen; Sztojkov-Ivanov Anita; Szűcs Kálmán Ferenc; Vari Sandor G.:
High Fat High Sucrose Diet Modifies Uterine Contractility and Cervical Resistance in Pregnant Rats: The Roles of Sex Hormones, Adipokines and Cytokines.
LIFE-BASEL, 12 (6).
Terjedelem: 18 p.-Azonosító: 794.
ISSN 2075-1729
(2022)
Seikrit Claudia; Lausberg Eva; Buhl Eva Miriam; Gáspár Róbert; Tábi Tamás; Heffer Marija; Ducza Eszter; Sztojkov-Ivanov Anita; Seres Adrienn; Szűcs Kálmán Ferenc; Ivic Vedrana; Floege Jürgen; Vari Sandor G.; Boor Peter; Klinkhammer Barbara Mara:
A Hypercaloric Diet Induces Early Podocyte Damage in Aged, Non-Diabetic Rats.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 55 (S4).
pp. 96-112.
ISSN 1015-8987
(2021)
Tábi Tamás; Vécsei László; Youdim Moussa B.; Riederer Peter; Szökő Éva:
Selegiline : a molecule with innovative potential.
JOURNAL OF NEURAL TRANSMISSION, 127.
pp. 831-842.
ISSN 0300-9564
(2020)
Szökő Éva; Tábi Tamás; Riederer Peter; Vécsei László; Magyar Kálmán:
Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson’s disease.
JOURNAL OF NEURAL TRANSMISSION, 125 (11).
pp. 1735-1749.
ISSN 0300-9564
(2018)
Tábi Tamás; Szökő Éva; Vécsei László; Magyar Kálmán:
The pharmacokinetic evaluation of selegiline ODT for the treatment of Parkinson’s disease.
Expert Opinion on Drug Metabolism and Toxicology, 9 (5).
pp. 629-636.
ISSN 1742-5255
(2013)
